Abstract
Non-histaminergic TRPA1 neural pathway is required for the development of allergic ocular itch. Pharmacological inhibition of TRPA1 channel can lead to novel therapeutic strategies to treat ocular itch in severe allergic conjunctivitis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have